L. Visser

发表

Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats.

L. Deelman, H. Buikema, R. Slart, 2021, Vascular pharmacology.

Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus

G. Pasterkamp, H. van Goor, J. Hillebrands, 2022, Cardiovascular Diabetology.

Immune modulation in MS models by peptidoglycan, CD97 and CD44

L. Visser, 2005 .

CD97 in leukocyte trafficking.

P. Tak, H. van Eenennaam, A. Boots, 2010, Advances in experimental medicine and biology.

Novel monoclonal antibodies against proteolipid protein peptide 139–151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions

J. Laman, C. Maassen, C. D. Groot, 2001, Journal of Neuroimmunology.

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide

M. Kap, J. Laman, C. Schwärzler, 1998, Multiple sclerosis.

IFN-β modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse

C. Lucas, L. Visser, L. Nagelkerken, 1999, Journal of Neuroimmunology.

Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis

R. Hintzen, J. Laman, J. Hamann, 2002, Journal of Neuroimmunology.

Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease

B. Lambrecht, J. Laman, U. Zähringer, 2005, The Journal of Immunology.

Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

R. Hintzen, B. '. ’t Hart, J. Laman, 2006, The American journal of pathology.

Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens.

J. Laman, C. van Holten-Neelen, E. Claassen, 2003, Vaccine.

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.

H. Codrington, P. Brocken, L. Visser, 2021, Journal of geriatric oncology.